介绍一种保留颈内动脉切除颈动脉体瘤的新方法——显微凝切法

张庆, 华清泉, 华荣恺, 等. 介绍一种保留颈内动脉切除颈动脉体瘤的新方法——显微凝切法[J]. 临床耳鼻咽喉头颈外科杂志, 2024, 38(9): 812-817. doi: 10.13201/j.issn.2096-7993.2024.09.007
引用本文: 张庆, 华清泉, 华荣恺, 等. 介绍一种保留颈内动脉切除颈动脉体瘤的新方法——显微凝切法[J]. 临床耳鼻咽喉头颈外科杂志, 2024, 38(9): 812-817. doi: 10.13201/j.issn.2096-7993.2024.09.007
ZHANG Qing, HUA Qingquan, HUA Rongkai, et al. To introduce a new method of resection of carotid body tumor with preservation of the internal carotid artery——microscopic coagulation method[J]. J Clin Otorhinolaryngol Head Neck Surg, 2024, 38(9): 812-817. doi: 10.13201/j.issn.2096-7993.2024.09.007
Citation: ZHANG Qing, HUA Qingquan, HUA Rongkai, et al. To introduce a new method of resection of carotid body tumor with preservation of the internal carotid artery——microscopic coagulation method[J]. J Clin Otorhinolaryngol Head Neck Surg, 2024, 38(9): 812-817. doi: 10.13201/j.issn.2096-7993.2024.09.007

介绍一种保留颈内动脉切除颈动脉体瘤的新方法——显微凝切法

详细信息
    通讯作者: 华清泉,E-mail:hqqrm@sina.com
  • 中图分类号: R543.5

To introduce a new method of resection of carotid body tumor with preservation of the internal carotid artery——microscopic coagulation method

More Information
  • 目的 介绍保留颈内动脉切除颈动脉体瘤(carotid body tumor,CBT)的手术经验。方法 回顾性分析109例CBT患者的临床资料,总结手术技术要点,综合分析影像学及病理结果,观察患者术后并发症。结果 109例患者中Shamblin Ⅰ型28例,Shamblin Ⅱ型46例,Shamblin Ⅲ型35例。突触素(SYN)和可溶性蛋白-100(S-100)均呈阳性。17例患者病理组织免疫组织化学S-100与SYN平均表达面积百分比存在正相关关系(r=0.48)差异有统计学意义(P < 0.05)。手术平均时长为(148.4±46.2) min,术中平均出血量为(64.7±22.8) mL,住院平均时间为(15.2±2.6) d。所有患者手术方法均为显微凝切法,其中3例患者切除肿瘤合并颈外动脉结扎术,1例行肿瘤切除合并颈内动脉结扎术,其他患者均行单纯肿瘤切除术。总体术中血管结扎率为3.7%,神经损伤率为6.4%。根据术前CTA、术中情况及术后病理结果,对CBT提出新的分型,直观反映肿瘤与颈动脉的间隙以及肿瘤性质。结论 建议确诊后手术切除CBT。显微镜下寻找肿瘤与血管之间的潜在间隙,运用低能量双极电凝凝闭并切断其间的纤维结缔组织,沿动脉外膜逐渐分离,在完整切除肿瘤同时大部分病例均可做到保留颈动脉,减少术中出血量,降低并发症发生率。术前如何识别手术困难病例尤为重要。
  • 加载中
  • 图 1  颈部CTA薄层扫描骨窗图像

    图 2  CBT手术切除步骤

    图 3  颈部CTA薄层扫描骨窗图像

    图 4  CBT手术切除步骤

    图 5  颈部CTA薄层扫描骨窗图像

    图 6  颈部CTA薄层扫描骨窗图像

    图 7  SYN与S-100的免疫组织化学图像(× 200)

    图 8  SYN与S-100的免疫组织化学图像(× 200)

    表 1  患者手术相关情况 X±S

    项目 Shamblin Ⅰ、Ⅱ型(n=74) Shamblin Ⅲ型(n=35) P
    手术时长/min 143.1±50.0 159.7±34.8 0.080
    术中出血量/mL 61.8±21.9 70.9±23.7 0.051
    住院时间/d 14.9±2.9 15.8±1.3 0.090
    下载: 导出CSV

    表 2  术中血管结扎及神经损伤情况 %

    项目 Shamblin
    Ⅰ型(n=28)
    Shamblin
    Ⅱ型(n=46)
    Shamblin
    Ⅲ型(n=35)
    血管结扎率 0 0 11.4
      ECA 0 0 3.0
      ICA 0 0 1.0
      CCA 0 0 0
    颅神经损伤率 0 6.5 11.4
      Ⅹ 0 1.0 2.0
      Ⅻ 0 2.0 2.0
    下载: 导出CSV
  • [1]

    Robertson V, Poli F, Hobson B, et al. A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours[J]. Eur J Vasc Endovasc Surg, 2019, 57(4): 477-486. doi: 10.1016/j.ejvs.2018.10.038

    [2]

    Zhang W, Liu F, Hou K, et al. Surgical outcomes and factors associated with malignancy in carotid body tumors[J]. J Vasc Surg, 2021, 74(2): 586-591. doi: 10.1016/j.jvs.2020.12.097

    [3]

    Davila VJ, Chang JM, Stone WM, et al. Current surgical management of carotid body tumors[J]. J Vasc Surg, 2016, 64(6): 1703-1710. doi: 10.1016/j.jvs.2016.05.076

    [4]

    Zhang JB, Fan XQ, Zhen YN, et al. Impact of preoperative transarterial embolization of carotid body tumor: a single center retrospective cohort experience[J]. Int J Surg, 2018, 54(Pt A): 48-52.

    [5]

    Munakomi S, Chaudhary S, Cherian I. Case Report: Managing a giant, high-grade carotid body tumor in a resource-limited setting[J]. F1000Res, 2017, 6: 1801. doi: 10.12688/f1000research.12726.1

    [6]

    Hua Q, Xu Z, Jiang Y. Diagnosis and surgical treatment of carotid body tumor: a retrospective analysis of 58 patients[J]. Oncol Lett, 2017, 14(3): 3628-3632. doi: 10.3892/ol.2017.6582

    [7]

    Mourad M, Saman M, Stroman D, et al. Evaluating the role of embolization and carotid artery sacrifice and reconstruction in the management of carotid body tumors[J]. Laryngoscope, 2016, 126(10): 2282-2287. doi: 10.1002/lary.26006

    [8]

    Spinelli F, Massara M, la Spada M, et al. A simple technique to achieve bloodless excision of carotid body tumors[J]. J Vasc Surg, 2014, 59(5): 1462-1464. doi: 10.1016/j.jvs.2013.10.075

    [9]

    吕海丽, 李谱, 张名霞, 等. 颈动脉体瘤术后16年发生颈部淋巴结转移1例[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(6): 475-476. https://lceh.whuhzzs.com/article/doi/10.13201/j.issn.2096-7993.2022.06.014

    [10]

    Jiang XL, Fang G, Guo DQ, et al. Surgical management of carotid body tumor and risk factors of postoperative cranial nerve injury[J]. World J Surg, 2020, 44(12): 4254-4260. doi: 10.1007/s00268-020-05723-8

    [11]

    卞策, 汪忠镐. 颈动脉体瘤的诊治要点[J]. 国际外科学杂志, 2014, 41(12): 793-795. doi: 10.3760/cma.j.issn.1673-4203.2014.12.001

    [12]

    Gao LY, Zhang XY, Jiang YX, et al. Assessment of carotid body tumors by superb microvascular imaging of feeding arteries during preoperative evaluation[J]. Front Surg, 2022, 9: 816768. doi: 10.3389/fsurg.2022.816768

    [13]

    Hogan AR, Sola JE, Jernigan SC, et al. A pediatric carotid body tumor[J]. J Pediatr Surg, 2018, 53(7): 1432-1436. doi: 10.1016/j.jpedsurg.2018.04.004

    [14]

    肖泽彬, 曹代荣, 江飞, 等. 320排CT诊断头颈部副神经节瘤[J]. 中国医学影像技术, 2014, 30(11): 1641-1644. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX201411015.htm

    [15]

    谢章弘, 华清泉. 92例颈动脉体瘤患者的诊断与外科治疗经验分析[J]. 中国医师杂志, 2020, 22(8): 1135-1138. doi: 10.3760/cma.j.cn431274-20200727-01043

    [16]

    陈婷, 沈暘, 朱江. 颈动脉体瘤的外科治疗及并发症预防与处理[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(9): 713-716. https://lceh.whuhzzs.com/article/doi/10.13201/j.issn.1001-1781.2018.09.018

    [17]

    Shiga K, Katagiri K, Ikeda A, et al. Challenges of surgical resection of carotid body tumors-multiple feeding arteries and preoperative embolization[J]. Anticancer Res, 2022, 42(2): 645-652. doi: 10.21873/anticanres.15522

    [18]

    Metheetrairut C, Chotikavanich C, Keskool P, et al. Carotid body tumor: a 25-year experience[J]. Eur Arch Otorhinolaryngol, 2016, 273(8): 2171-2179. doi: 10.1007/s00405-015-3737-z

  • 加载中

(8)

(2)

计量
  • 文章访问数:  773
  • PDF下载数:  228
  • 施引文献:  0
出版历程
收稿日期:  2024-02-18
刊出日期:  2024-09-03

目录